Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2006-5-17
pubmed:abstractText
Campath-1H preconditioning with tacrolimus monotherapy is an effective immunosuppressive regimen for pancreas transplantation, with acceptable patient and graft survival rates early after transplantation. Rejection rates are low under this protocol if the tacrolimus level is kept consistently >10 ng/ml. This immunosuppressive protocol, combined with recent technical refinements, has resulted in lower rates of thrombosis and overall complications. Pancreatic transplantation en-bloc with visceral grafts has the following unique features: Diabetes is a rare indication, and HLA matching is not required. The gland is immunologically protected by the simultaneously transplanted visceral organs. Disease gravity, surgical complexity and gut alloimmunity influence the overall pancreatic allograft survival. The current UNOS listing criteria and data registry should be modified for obvious logistic and scientific reasons.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16704151-10075595, http://linkedlifedata.com/resource/pubmed/commentcorrection/16704151-10371508, http://linkedlifedata.com/resource/pubmed/commentcorrection/16704151-10949181, http://linkedlifedata.com/resource/pubmed/commentcorrection/16704151-11066140, http://linkedlifedata.com/resource/pubmed/commentcorrection/16704151-11524593, http://linkedlifedata.com/resource/pubmed/commentcorrection/16704151-11905833, http://linkedlifedata.com/resource/pubmed/commentcorrection/16704151-12465547, http://linkedlifedata.com/resource/pubmed/commentcorrection/16704151-12717215, http://linkedlifedata.com/resource/pubmed/commentcorrection/16704151-12737859, http://linkedlifedata.com/resource/pubmed/commentcorrection/16704151-15008165, http://linkedlifedata.com/resource/pubmed/commentcorrection/16704151-15077039, http://linkedlifedata.com/resource/pubmed/commentcorrection/16704151-2028370, http://linkedlifedata.com/resource/pubmed/commentcorrection/16704151-3551646, http://linkedlifedata.com/resource/pubmed/commentcorrection/16704151-6382661, http://linkedlifedata.com/resource/pubmed/commentcorrection/16704151-9583691
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0890-9016
pubmed:author
pubmed:issnType
Print
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
205-14
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:16704151-Adolescent, pubmed-meshheading:16704151-Adult, pubmed-meshheading:16704151-Antibodies, Monoclonal, pubmed-meshheading:16704151-Antibodies, Monoclonal, Humanized, pubmed-meshheading:16704151-Antibodies, Neoplasm, pubmed-meshheading:16704151-Child, pubmed-meshheading:16704151-Diabetes Mellitus, Type 1, pubmed-meshheading:16704151-Graft Rejection, pubmed-meshheading:16704151-Graft Survival, pubmed-meshheading:16704151-Humans, pubmed-meshheading:16704151-Immunosuppressive Agents, pubmed-meshheading:16704151-Middle Aged, pubmed-meshheading:16704151-Pancreas, pubmed-meshheading:16704151-Pancreas Transplantation, pubmed-meshheading:16704151-Pennsylvania, pubmed-meshheading:16704151-Survival Rate, pubmed-meshheading:16704151-Tacrolimus, pubmed-meshheading:16704151-Tissue Donors, pubmed-meshheading:16704151-Transplantation Conditioning
pubmed:year
2004
pubmed:articleTitle
Pancreatic transplantation at the University of Pittsburgh.
pubmed:affiliation
The Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
pubmed:publicationType
Journal Article